The INFINITY Phase 2 trial is a randomized, active comparator-controlled trial evaluating a single intravitreal injection of ADVM-022 gene therapy candidate in patients with diabetic macular edema (DME).

 
Contact us to learn more
INFINITYtrial@adverum.com

More information is available at www.clinicaltrials.gov.